ADC Therapeutics Ltd ADCT 深 滬
已收盤 02-06 16:00:00 美东时间
4.01
+0.100
+2.56%
華盛通- 最 高4.195
- 今 開3.97
- 成交量 104.74万股
- 最 低 3.93
- 昨 收 3.91
- 總市值 4.97亿
- 52周最高 4.80
- 市盈率 靜 --
- 換手率 0.85%
- 52周最低 1.05
- 委 比 33.77%
- 總股本 1.24亿
- 歷史最高 56.59
- 量 比 1.46
- 振 幅 6.78%
- 歷史最低 0.3599
- 每 手 1
- 風險率 1.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
LAUSANNE, Switzerland, Feb. 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today anno...
02-03 05:05
$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium
Issued on behalf of Oncolytics Biotech Inc. Equity-Insider.com News Commentary VANCOUVER, BC, Jan. 30, 2026 /PRNewswire/ -- The oncology sector is undergoing a massive capital rotation driv...
01-30 23:36
ADC Therapeutics posts preliminary 2025 revenue of about $73M
ADC Therapeutics SA (ADCT) said on Thursday it expects preliminary unaudited net product revenue of about $22 million for the fourth quarter of 2025 and approximately $73 million for the full year. Th...
01-09 05:25
ADC Therapeutics Reports Q4, 2025 Preliminary ZYNLONTA Net Product Revenue Of ~$22M, ~$73M, Respectively
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today provided corporate updates and highlights from its ZYNLONTA® clinical program.
01-09 05:16
ADC Therapeutics Announces New Employee Inducement Grant
LAUSANNE, Switzerland, Jan. 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today anno...
01-03 05:05
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines
Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ -- Equity Insider News Commentary – The oncology sector's pivot toward platform-based precision therapies has...
2025-12-19 20:55
Snowflake, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around...
2025-12-04 21:00
Why Is ADC Therapeutics Plunging Today
Zynlonta and glofitamab show high response and durable remission rates in early r/r DLBCL trial data from ADC Therapeutics, with enrollment ongoing into 2026.
2025-12-04 03:40
ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial
Company to host corporate webcast to share updated data on December 3, 2025 LAUSANNE, Switzerland, Dec. 2, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global le...
2025-12-03 05:05
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
LAUSANNE, Switzerland, Dec. 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today anno...
2025-12-02 05:05
